Literature DB >> 14703522

Treatment of major depressive disorder in children and adolescents.

Paul Ramchandani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14703522      PMCID： PMC313880          DOI： 10.1136/bmj.328.7430.3

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder.

Authors:  R Harrington; J Whittaker; P Shoebridge; F Campbell
Journal:  BMJ       Date:  1998-05-23

Review 2.  Tricyclic drugs for depression in children and adolescents.

Authors:  P Hazell; D O'Connell; D Heathcote; D Henry
Journal:  Cochrane Database Syst Rev       Date:  2000

3.  Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-10       Impact factor: 79.321

4.  Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up.

Authors:  J G Simeon; V F Dinicola; H B Ferguson; W Copping
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1990       Impact factor: 5.067

5.  Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis.

Authors:  P Hazell; D O'Connell; D Heathcote; J Robertson; D Henry
Journal:  BMJ       Date:  1995-04-08

6.  A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

Authors:  G J Emslie; A J Rush; W A Weinberg; R A Kowatch; C W Hughes; T Carmody; J Rintelmann
Journal:  Arch Gen Psychiatry       Date:  1997-11

7.  Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials.

Authors:  Karen Dineen Wagner; Paul Ambrosini; Moira Rynn; Christopher Wohlberg; Ruoyong Yang; Michael S Greenbaum; Ann Childress; Craig Donnelly; Deborah Deas
Journal:  JAMA       Date:  2003-08-27       Impact factor: 56.272

8.  Mental health of children and adolescents in Great Britain.

Authors:  H Meltzer; R Gatward; R Goodman; T Ford
Journal:  Int Rev Psychiatry       Date:  2003 Feb-May

9.  Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial.

Authors:  Graham J Emslie; John H Heiligenstein; Karen Dineen Wagner; Sharon L Hoog; Daniel E Ernest; Eileen Brown; Mary Nilsson; Jennie G Jacobson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2002-10       Impact factor: 8.829

10.  Cost of depression among adults in England in 2000.

Authors:  Christine M Thomas; Stephen Morris
Journal:  Br J Psychiatry       Date:  2003-12       Impact factor: 9.319
  10 in total
  9 in total

1.  [Administration of selective serotonin reuptake inhibitors (SSRI) for depression in children and adolescents].

Authors:  J M Fegert; B Herpertz-Dahlmann
Journal:  Nervenarzt       Date:  2004-09       Impact factor: 1.214

2.  Increase in non-evidence based use of antidepressants in children is cause for concern.

Authors:  Antonio Clavenna; Maurizio Bonati; Elisa Rossi; Marisa De Rosa
Journal:  BMJ       Date:  2004-03-20

3.  Treating major depression in children and adolescents: depressed adolescents may lose out.

Authors:  Kenneth D Shenderey
Journal:  BMJ       Date:  2004-02-28

4.  Treating major depression in children and adolescents: research is needed into safer and more effective drugs.

Authors:  Macey L Murray; Ian C K Wong; Corinne S de Vries
Journal:  BMJ       Date:  2004-02-28

5.  Treating major depression in children and adolescents: use of selective serotonin reuptake inhibitors needs urgent clarification.

Authors:  Andrew Herxheimer
Journal:  BMJ       Date:  2004-02-28

Review 6.  Rethinking childhood depression.

Authors:  Sami Timimi
Journal:  BMJ       Date:  2004-12-11

7.  Young adults' reluctance to seek help and use medications for mental distress.

Authors:  Lucy Biddle; David Gunnell; Jenny Donovan; Debbie Sharp
Journal:  J Epidemiol Community Health       Date:  2006-05       Impact factor: 3.710

8.  Therapeutic identification of depression in young people: lessons from the introduction of a new technique in general practice.

Authors:  Steve Iliffe; Ceri Gallant; Tami Kramer; Julia Gledhill; Amanda Bye; Victoria Fernandez; Mar Vila; Lisa Miller; M Elena Garralda
Journal:  Br J Gen Pract       Date:  2012-03       Impact factor: 5.386

Review 9.  A new paradigm for developing drugs in children: atomoxetine as a model.

Authors:  S Prasad
Journal:  Arch Dis Child       Date:  2005-02       Impact factor: 3.791
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.